Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia by Kantarjian, H. M., Padmanabhan, S., Stock, W., Tallman, M. S., Curt, G. A., Li, J., Osmukhina, A., Wu, K., Huszar, D., Borthukar, G., Faderl, S., Garcia-Manero, G., Kadia, T., Sankhala, K., Odenike, O., Altman, J. K., Minden, M.

Get full text